PHENORIS ONT DIN 00428078
Health Canada record
| Active ingredient(s) | CLIOQUINOL 2 %; ALLANTOIN 1 %; PHENOL .25 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | D09AA20 COMBINATIONS OF ANTIINFECTIVES |
| Original market date | 31-Dec-1978 |
| Current status date | 07-Dec-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLIOQUINOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00074500 | VIOFORM HYDROCORTISONE | KNIGHT THERAPEUTICS INC. | Cream | CLIOQUINOL 3 %; HYDROCORTISONE 1 % | Marketed |
| 02181150 | PHEN-ORIS - ONT TOP | GERMIPHENE CORPORATION | Ointment | CLIOQUINOL 2 %; ALLANTOIN 1 %; PHENOL .25 % | Cancelled Post Market |
| 00074527 | VIOFORM + HYDROCORTISONE | CIBA PHARMACEUTICALS, CIBA-GEIGY CANADA LTD. | Ointment | CLIOQUINOL 3 %; HYDROCORTISONE 1 % | Cancelled Post Market |
| 00005142 | VIOFORM 3% | NOVARTIS PHARMACEUTICALS CANADA INC | Cream | CLIOQUINOL 3 % | Cancelled Post Market |
| 00005797 | VIOFORM 3% | NOVARTIS PHARMACEUTICALS CANADA INC | Ointment | CLIOQUINOL 3 % | Cancelled Post Market |
| 00074489 | VIOFORM HYDROCORTISONE MILD | NOVARTIS PHARMACEUTICALS CANADA INC | Cream | CLIOQUINOL 3 %; HYDROCORTISONE 0.5 % | Cancelled Post Market |
International API supply for CLIOQUINOL
1 active FDA Drug Master Files.
Request a quote for PHENORIS ONT